» Articles » PMID: 31110626

Gestational Trophoblastic Disease at Sultan Qaboos University Hospital: Prevalence, Risk Factors, Histological Features, Sonographic Findings, and Outcomes

Overview
Journal Oman Med J
Specialty General Medicine
Date 2019 May 22
PMID 31110626
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We sought to assess the prevalence of gestational trophoblastic diseases (GTD) among pregnant women at Sultan Qaboos University Hospital (SQUH) and compare our results with the international studies. We also sought to determine the risk factors, histological features, sonographic findings, and outcomes in women with GTD.

Methods: We conducted a retrospective cohort study of all women diagnosed with GTD and followed at SQUH between November 2007 and October 2015. We collected data on maternal demographics, risk factors, sonographic features, histological diagnosis, follow-up period, and chemotherapy treatment from the hospital information system.

Results: Sixty-four women with GTD were included in the study with a mean age of 31.0±7.5 years, mean gravidity 4.0, and parity 2.0. The prevalence of GTD was 0.3% (one in 386 births), and the most common risk factors were increased maternal age and multiparity. A partial hydatidiform mole was diagnosed in 54.7%, complete hydatidiform mole in 43.8%, and invasive mole in 1.6% of women. Eleven percent of women required chemotherapy. Typical ultrasound features for partial molar pregnancy were present in 54.7% of our sample, while snowstorm appearance was seen in 89.3% of those with complete mole. Negative beta-human chorionic gonadotropin was achieved 70 days after diagnosis in 41 women.

Conclusions: The awareness of the risks and complications of GTD among physicians with close follow-up is paramount. There is a need to establish a national registry of GTD cases in Oman.

Citing Articles

Analysis of Fertility Prognosis and Risk Factors in Patients Post-Gestational Trophoblastic Disease.

Wang R, Ge Y, Dong X, Wang H, Wang L, Gao M Reprod Sci. 2024; 31(10):3095-3101.

PMID: 39026051 DOI: 10.1007/s43032-024-01594-9.


Review of current literature on gestational trophoblastic neoplasia.

Shahzadi M, Khan S, Tariq M, Baloch S, Shahid A, Moosajee M J Egypt Natl Canc Inst. 2023; 35(1):37.

PMID: 38008872 DOI: 10.1186/s43046-023-00195-y.


Clinical Features of Gestational Trophoblastic Disease in Aged Women in South Vietnam.

Nguyen B, Vo T, Thi Thuy Phan V, Nguyen C, Vu H, Vo B Yonsei Med J. 2023; 64(4):284-290.

PMID: 36996900 PMC: 10067792. DOI: 10.3349/ymj.2022.0241.


Ten-Year Review of Gestational Trophoblastic Disease at Lady Reading Hospital, Peshawar.

Hussain S, Raees M, Rahim R Cureus. 2022; 14(7):e26620.

PMID: 35936190 PMC: 9356217. DOI: 10.7759/cureus.26620.


A review on management of gestational trophoblastic neoplasia.

Sharami S, Saffarieh E J Family Med Prim Care. 2020; 9(3):1287-1295.

PMID: 32509606 PMC: 7266251. DOI: 10.4103/jfmpc.jfmpc_876_19.


References
1.
Seckl M, Fisher R, Salerno G, Rees H, Paradinas F, Foskett M . Choriocarcinoma and partial hydatidiform moles. Lancet. 2000; 356(9223):36-9. DOI: 10.1016/S0140-6736(00)02432-6. View

2.
Lorigan P, Sharma S, Bright N, Coleman R, Hancock B . Characteristics of women with recurrent molar pregnancies. Gynecol Oncol. 2000; 78(3 Pt 1):288-92. DOI: 10.1006/gyno.2000.5871. View

3.
Sebire N, Foskett M, Fisher R, Rees H, Seckl M, NEWLANDS E . Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age. BJOG. 2002; 109(1):99-102. DOI: 10.1111/j.1471-0528.2002.t01-1-01037.x. View

4.
Sebire N, Rees H, Paradinas F, Seckl M, NEWLANDS E . The diagnostic implications of routine ultrasound examination in histologically confirmed early molar pregnancies. Ultrasound Obstet Gynecol. 2002; 18(6):662-5. DOI: 10.1046/j.0960-7692.2001.00589.x. View

5.
Kumar N, Saxena Y, Rathi A, Chitra R, Kumar P . Host and risk factors for gestational trophoblastic disease: a hospital-based analysis from India. Med Sci Monit. 2003; 9(10):CR442-7. View